Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis

Stephen L. Pinkosky(Esperion Therapeutics (United States)), Narendra D. Lalwani(Esperion Therapeutics (United States))

Nature Communications

November 28, 2016

10.1038/ncomms13457

Cited by 475

Related Papers

Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol

|New England Journal of Medicine|2019|794

AMP-activated protein kinase and ATP-citrate lyase are two distinct molecular targets for ETC-1002, a novel small molecule regulator of lipid and carbohydrate metabolism

|Journal of Lipid Research|2012|234